Key facts
- Notable investors include Suzhou Oriza Holdings Corporation, Jolmo Investment, Changshu Guofa Venture Capital, Creacion Ventures, Sibionics.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Singmed
- ·The full record, as it builds
Funding rounds
No funding rounds for Singmed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Singmed
Manufacturer of advanced medical devices intended to improve drug delivery and diagnostic effectiveness. The company offers inhalation systems, nasal spray platforms, and drug-device combination products, enabling healthcare professionals and patients access to reliable respiratory therapies and affordable treatment options.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2016
- Employees
- 29
- Website
- singmed.cn/
- Ownership
- Privately Held (backing)
Singmed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Singmed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Singmed in its N-PORT filings yet. We sweep new filings monthly.